The 2021 Academician Co-optation of the Chinese Academy of Sciences has completed the communication review work. In accordance with the provisions of the Statute of Academicians of the Chinese Academy of Sciences and the Detailed Rules for the Implementation of the Co-election of Academicians of the Chinese Academy of Sciences, the preliminary list of candidates is hereby announced.
Cas
August 1, 2021
A total of 191 candidates were selected for the second round of accreditation, including 36 from the Faculty of Life Sciences and Medicine.
1. Gender statistics: 32 men, 4 women, males accounted for 88.89%;
2. Age statistics: the oldest is 66 years old, the youngest is 43 years old, and the average age is 57 years old;
3. Unit distribution: 10 members of the Chinese Academy of Sciences system, 3 people of the Chinese People's Liberation Army Academy of Military Sciences, 3 people of Peking University, 2 people of Zhejiang University, 2 people of Wuhan University, 2 people of Huazhong University of Science and Technology, 2 people of Capital Medical University, 2 people of Chinese People's Liberation Army General Hospital, 1 person of Southeast University, 1 person of Tsinghua University, 1 person of Xiamen University, 1 person of Shanghai Jiao Tong University, 1 person of Wenzhou Medical University, 1 person of Yunnan University, 1 person of Air Force Military Medical University, 1 person of Chinese Academy of Agricultural Sciences, 1 person of Peking Union Medical College, 1 person of Sichuan Provincial People's Hospital/ University of Electronic Science and Technology of China has 1 person.
Preliminary list of candidates for the 2021 Academician Co-election of the Chinese Academy of Sciences
(Faculty of Life Sciences and Medicine) (surname pinyin in order)
Introduction of preliminary candidates for the co-election of academicians of the Chinese Academy of Sciences
Cai Xiujun, famous surgery expert, professor, chief physician, doctoral supervisor, president of Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine. He is also the vice chairman of the Surgery Branch of the Chinese Medical Association, the chairman of the Minimally Invasive Surgeon Committee of the Surgeon Branch of the Chinese Medical Doctor Association, a member of the Clinical Medicine Discipline Review Group of the Degree Committee of the State Council, a central health consultation expert, the head of the innovation team in the key areas of the Ministry of Science and Technology, the American Academy of Surgeons Fellow, the Royal College of Surgeons Of the United Kingdom, the "Yangtze River Scholar" Distinguished Professor of the Ministry of Education (2009-2012), and the first batch of "special experts" in Zhejiang Province. He has won 1 second prize of national technological invention, 2 second prizes of national scientific and technological progress, 1 first prize of scientific and technological progress of the Ministry of Education, 3 first prizes of scientific and technological progress of Zhejiang Province, Liang Heli Science and Technology Innovation Award, Zhejiang Science and Technology Award Major Contribution Award, Wu Jieping Pharmaceutical Innovation Award, etc. He established laparoscopic scraping anatomical hepatic resection, laparoscopic regional hepatic blood flow blocking technology, completed the first complete laparoscopic two-step liver resection around the liver band method in the world, and created the first minimally invasive medical discipline in China.
Cao Wuchun, researcher, major general of professional technology, winner of the National Science Foundation for Outstanding Young Scholars. He is currently the chief expert of the Academy of Military Sciences and the director of the State Key Laboratory of Biosafety of Pathogenic Microorganisms. He was selected into the National 100 Million Talents Project, was awarded the honorary title of "Young and Middle-Aged Experts with Outstanding Contributions", and enjoyed the special government allowance of the State Council; won the National Scramble for Innovation Award, Wu Jieping-Paul × Yangsen Medical Pharmacy Award, Public Health and Preventive Medicine Development Contribution Award, And Military Outstanding Professional and Technical Talent Award; is an advanced individual in the national fight against the new crown pneumonia epidemic, an academic leader of the Innovative Research Group of the National Natural Science Foundation of China; a leading talent in military science and technology; and a first-class meritorious service.
Lingling Chen graduated from the University of Connecticut School of Medicine with a Ph.D. in Biomedical Sciences in 2009 and a Master of Business Administration degree from the School of Business. In May of the same year, he was awarded the Connecticut Stem Cell Seed Award as an independent PI, and was hired as a postdoctoral researcher at the School of Stem Cell at the University of Connecticut, and was appointed as an assistant professor in May 2010 and a researcher at the Shanghai Institute of Biochemistry and Cell research in January 2011.
She currently serves as the editorial board of Several international journals such as Cell and Mol Cell, the Conference Chair of the Non-Coding RNA Conference of Cold Spring Harbor Laboratory in the United States, the Annual Conference of the International RNA Association, etc., and was selected as an International Research Scholar of the Howard Hughes Medical Institute (HHMI) in 2017, and has been funded by the National Outstanding Youth Science Foundation, and has won the Special Award of the China Youth Science and Technology Award, the Science Exploration Award, the Tan Jiazhen Life Science Innovation Award, The CBIS Young Researcher Award of the Global Chinese Biologist Association and the Young Women Scientist Award of China and other honors.
Dou Kefeng, male, Han ethnicity, born in February 1956, from Qianxian County, Shaanxi Province, is a member of the Communist Party of China. In October 2020, he was selected into the list of "2020 People's Good Doctors". He is mainly engaged in the basic and clinical research of liver transplantation, liver cancer, and the treatment of abdominal warfare and trauma. Systematically grasp the knowledge of international frontier fields such as liver tumors, liver transplantation and biliary tumors.
Dou Kefeng has always aimed at the forefront of science and technology in the world, and has successively presided over the mechanism and prevention of oxygen radical and hepatic ischemia reperfusion injury, MHC tetramer induced transplant immune tolerance, and the construction and screening of liver cancer single-chain antibody library. Professor Dou Kefeng actively advocated living organ transplantation, and successively presided over the first successful living liver partial transplantation in China, the auxiliary in situ living liver partial transplantation with different blood types, and the living donor liver partial transplantation at the youngest age in China at that time, and continued to maintain the record of the longest survival time of living liver transplantation in China. He has also carried out a wide range of whole liver transplantation procedures, and successfully completed innovative surgeries such as liver transplantation, liver transplantation combined with pancreatic duodenal resection under complex conditions at the highest altitude in the world, hepatic-renal-pancreatic combined transplantation with the longest survival time in Asia, and single-segment transplantation.
In addition, he took the lead in carrying out argon helium knife treatment of middle and advanced liver cancer, colon cancer liver metastasis, etc. in China, and achieved satisfactory results. He adopted the method of separation and complete resection along the envelope of hepatic hemangioma to treat hepatic giant hemangioma, and proposed the theory of "cutting tumor without cutting liver", which changed the previous method of cutting tumors and had to cut the liver, and greatly improved the treatment effect of hepatic hemangioma.
Caixia Gao, female, is a researcher at the State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and a doctoral supervisor. In 1991, he received a bachelor's degree from Gansu Agricultural University. In 1994, he obtained a master's degree from Gansu Agricultural University. He received his Ph.D. from China Agricultural University in 1997. 1997-1998 Postdoctoral Fellow, Research Department, DLF-Trifolium, Denmark. 1998-2009 Research Scientist, Research Scientist, Research Department, DLF-Trifolium, Denmark. In September 2009, he returned to China and served as a researcher and leader of the research group at the State Key Laboratory of Plant Cell and Chromosome Engineering of the Institute of Genetic Development, and was selected as an "Outstanding Technical Talent" of the Chinese Academy of Sciences in 2010.
He is mainly engaged in the research of plant genome editing technology, biosafety new breeding technology and genome editing directed design molecular breeding, and is committed to promoting the application of genome editing in molecular design breeding.
He Guangcun, male, professor and doctoral supervisor. Outstanding young and middle-aged experts with outstanding contributions in Hubei Province, outstanding scientists enjoying special allowances from the State Council. Professor Ho Kwong Cun served as Dean (third) of the School of Life Sciences and is currently the Head of the Department of Genetics. Director of the National Key Laboratory of Hybrid Rice, Han University.
He has been engaged in basic research and applied basic research in rice genetics for a long time. A series of important achievements have been made in the excavation, identification and functional research of new genes, and the first rice planthopper resistance gene Bph14 in rice has been cloned internationally; the anti-insect gene resources and molecular markers created have been widely used in various breeding units in China, which has promoted the development of rice insect resistance genetics and breeding in China.
Hu Hailan is a double-appointed professor and doctoral supervisor of Qiushi Institute for Advanced Study/School of Medicine of Zhejiang University, and the executive director of the Center for Neuroscience of Zhejiang University. Graduated from Peking University and the University of California, Berkeley. Postdoctoral Fellow, Cold Spring Harbor Laboratory. In 2008, he returned to China as a researcher at the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences. He joined Zhejiang University in May 2015. He has presided over a number of projects such as the "Hundred Talents Program" of the Chinese Academy of Sciences (excellent in the final evaluation) and the National Science Foundation for Outstanding Young People, and participated in the research work of the 973 Major Scientific Issues Orientation Project of the Ministry of Science and Technology and the Strategic Leading Science and Technology Special Project (Category B) of the Chinese Academy of Sciences as a backbone. Committed to the study of the molecular and neural circuit mechanisms of emotions and social behaviors, in the past six years, he has achieved a series of systematic original achievements with both theoretical significance and potential application value in the direction of emotional neural coding, molecular mechanisms of depression, and neural basis of social hierarchy. He has published several papers in journals such as Science, Nature, Cell, Nature Neuroscience, etc. The honors he has received include the Outstanding Mentor Award of the Chinese Academy of Sciences (twice), the Meiji Life Science Outstanding Award, the Sanofi Outstanding Scholar Award, the 12th China Women Scientist Award, and the China Youth Science and Technology Award. A number of outstanding doctoral graduates have been trained, and a total of 10 people have won the highest scholarships at the national level.
Huang Sanwen, male, researcher, born in September 1971, from Yueyang City, Hunan Province. Since February 2005, he has been appointed as a second-level talent of the Chinese Academy of Agricultural Sciences as the leader of the functional gene research group of the Biotechnology Laboratory of the Institute of Vegetables and Flowers. He is the chief scientist of the International Cucumber Genome Project and the International Haploid Potato Genome Project, which are plant genome projects initiated by China and multilaterally cooperated. In the construction of cucumber genetic map, cytogenetic map construction, sex expression research, disease resistance research and quality research, a number of research projects have been carried out, and the cucumber sex-determining gene M has been cloned, and the integrated map of cucumber heredity-cytogenetic integration has been constructed. He has made outstanding contributions to the study of potato resistance to late blight, analyzed in detail the genomic structure and functional differentiation of R3 in the disease-resistant gene locus, cloned the world's third potato anti-late blight gene R3a, and collaborated with British and American scientists to clone the world's first late blight non-toxic gene Avr3a, R3a-Avr3a is the first pair of systems in line with the concept of "gene-to-gene", which is a model for studying potato-late blight interaction system. Papers have been published in journals such as PNAS, Plant Journal, Plos One, Genetics, Molecular Plant-Microbe Interaction, and Theoretical Applied Genetics. He has published more than 30 academic papers, including 1 English monograph and 10 SCI papers, with an impact factor of 34.4, and has been cited 170 times by other SCI papers; since 2007, he has served as the associate editor of Euphytica (International Journal of Plant Breeding, SCI Journal, Impact Factor 1.1).
Huo Yong, male, professor, chief physician, doctoral supervisor, academician of the American College of Heart (FACC), Peking University First Hospital, is currently the director of the Department of Cardiology and Heart Science of Peking University First Hospital, specializing in the interventional treatment of coronary heart disease, hypertension and coronary heart disease.
In 2012, he won the 8th "Chinese Physician Award", the 13th Wu Jieping-Paul Janssen Medical Pharmacy Award and the "Wu Jieping Innovation Award". On May 29, 2020, it won the second National Innovation Scramble Award.
Professor Huo Yong has long been engaged in cardiology medical treatment, teaching and scientific research, and has rich clinical experience and skill in the diagnosis and treatment of cardiovascular difficulties and severe diseases. He has in-depth research on the interventional treatment of cardiovascular disease, is good at the interventional treatment of coronary heart disease, and has ranked first in the country in the number of individual coronary intervention cases and the total number of cases for many years.
Jia Jianping, neurologist, famous doctor of the country, central health expert, director of the Center for Neurological Diseases And Innovation Center of Xuanwu Hospital of Capital Medical University, professor, doctoral supervisor, beijing scholar. He has been engaged in clinical, scientific research and teaching of neurodegenerative diseases, Alzheimer's disease and related dementias for a long time. "Retrieving the lost memories of patients and improving people's brain health" is the goal of life. His research interests include the pathogenesis, peripheral markers, and clinical drug research of neurodegenerative diseases, Alzheimer's disease, and related dementia.
Professor Jia Jianping is the leader of the Department of Neurology in China; the leader and developer of Dementia and cognitive impairment diseases in China; the discovery of China's first AD family in 2003, gradually establishing the world's largest cohort of more than 610 AD families, successively reporting new mutations in AD genes in 40 Chinese people accounting for 10% of the world, according to which 11 domestically produced mouse models were constructed to achieve a breakthrough in China's AD animal model zero; and creating AD early recognition and prediction methods to advance AD intervention to the asymptomatic stage He presided over the formulation of 27 dementia guidelines at home and abroad, and standardized the standards for the diagnosis and treatment of AD. It was rated as a major progress in the research of dementia in China in 20 years. He was invited to write a special review of "The Current Situation and Future of Dementia in China" for Lancet Neurol.
Li Jinsong is a researcher and research team leader at the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. In 2008, he was supported by the "100 Talents Plan" project, in 2012 by the "Outstanding Youth Fund", in 2013 he was selected as the "Young and Middle-Aged Scientific and Technological Innovation Leading Talents", and in 2016, he was selected as the second batch of national "10,000 Talents Plan" leading talents.
In 2012, Li Jinsong's research group established solitary androgylotylotyloid embryonic stem cells from mouse sperm and demonstrated that these cells can replace sperm to "fertilize" oocytes to produce semi-clone mice (called "hemiclolon" technology). In 2015, the research team obtained haploid stem cells (birth efficiency of about 20%) that can stably and efficiently produce semi-cloned mice, so they are also called "artificial sperm cells". In 2018, the research group achieved in vivo genetic screening of protein-critical amino acids by combining "artificial sperm cells" and CRISPR-Cas9-mediated Base editor system.
Li Yixue, male, born in 1955, Ph.D., researcher, doctoral supervisor. Director of Shanghai Bioinformatics Research Center, Director of Bioinformatics Center of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, Deputy Director of Key Laboratory of Systems Biology, Chinese Academy of Sciences, member of the Expert Group in the Field of Biology and Medicine of the National Eleventh Five-Year Plan.
In 2003, he was a model worker in Shanghai and an outstanding discipline leader in Shanghai in 2003. He is currently a full-time review expert of the Natural Science Foundation of the National Natural Science Foundation of China, a special reviewer of the Journal of Integrative Bioinformatics in Germany, a special reviewer of the American Journal of Medical Science Monitor, a special editor of the domestic Science Bulletin, a journal of biophysics and biochemistry, a Chinese Journal of Biological Engineering, and Genomics, Proteomics and Editorial board member of Bioinformatics and other magazines.
Li Yi, male, professor, doctoral supervisor, professor of school of life sciences of Peking University, doctoral supervisor, winner of the "National Outstanding Youth Fund". Member of the Steering Committee for Biotechnology and Bioengineering in Colleges and Universities of the Ministry of Education. He is the director of the Plant Virus Professional Committee and the Plant-Pathogen Interaction Professional Committee of the Chinese Plant Pathology Society, and the deputy director of the Virus Professional Committee of the Chinese Society for Microbiology. The 973 program of the Ministry of Science and Technology, the 863 key project, the chief scientist of the major project of the State Fund Commission and the industry public welfare special project, MPMI and other publications Senior Editor. He was the President of the International MPMI and IBC Chapters.
His research interests include the interaction between viruses and plant hosts and the influence and pathogenic mechanism of virus infection on host development; the defense mechanism of plant hosts against viruses and the anti-defense mechanism of viruses; the interaction between viruses and propagating mediator insect hosts and the mechanism of mediator-borne viruses; the interference of viruses with the immune system of insect mediators and the antiviral immune mechanism of mediators.
Lin Shengcai, professor and doctoral supervisor of the School of Life Sciences of Xiamen University, the leading talent of the national "Ten Thousand Talents Program", has won the National Outstanding Youth Natural Science Foundation. In recent years, Professor Lin Shengcai has taken the steady-state regulation of cell metabolism as the core of his research, and has studied the mechanism of cell perception of nutrients and energy and the molecular mechanism of the occurrence and development of diseases related to metabolic disorders, and has achieved a series of original results. So far, he has published nearly 100 SCI papers, many of which have been published in internationally renowned journals such as Nature, Science, Cell Metabolism, Nature Cell Biology, Molecular Cell, etc., and have been cited more than 9,000 times.
Youming Lu, Professor/Doctoral Supervisor. Associate Dean of Tongji School of Medicine, Huazhong University of Science and Technology, Director of brain research institute of Huazhong University of Science and Technology, and tenured distinguished professor of Louisiana State University School of Medicine. He has long been committed to the study of the role and mechanism of glutamate receptors and ion channels in the physiological function of synapses and pathological processes such as ischemic hypoxic encephalopathy and neurodegenerative diseases.
For the first time in the world, tyrosine protein kinase SRC is involved in the formation of LTP by regulating glutamate NMDA receptors, and the series of research results have been published in the journals such as Cell, Science, Nature Neurosci, Neuron, J Neurosci and so on. He has received a number of U.S. and Canadian national research grants, is a reviewer of nature neurosci, neuron, j neurosci and other journals, an editorial board member of molecular neurobiology journals, and a review committee member of the United States NIH, Canada CIHR and other fund review committees. In 2011, he returned to China to work full-time.
Ma Ping, male, is a researcher at the Institute of Botany, Chinese Academy of Sciences, a professor and doctoral supervisor at the University of Chinese Academy of Sciences. He received a bachelor's degree from Qiqihar Normal University in 1982, a master's degree from Northeast Forestry University in 1987, and a doctorate from Northeast Forestry University in 1991. From 1991 to 1994, he was engaged in postdoctoral research at the Institute of Botany, and in January 1994, he stayed at the Institute as an associate researcher and became a researcher in December 1995. From August 1998 to June 2002, he was the director of the Research Center for Plant Ecology and Biodiversity Conservation of the Institute of Botany, from June 2002 to June 2006, he was the deputy director of the Institute of Botany, and from June 2006 to August 2010, he was the director of the Institute.
In recent years, it has mainly carried out research on community building mechanisms, conservation biogeography and biodiversity and ecosystem functions, and actively promoted the development of biodiversity informatics in China, especially the digitization of specimens and its sharing platform, the national inventory of biological species, the construction of China's biodiversity monitoring network and forest biodiversity and ecosystem function research platform.
Qi Yijun, male, professor of Tsinghua University, director of plant biology research center, vice dean of the School of Life Sciences, distinguished professor of the Ministry of Education, winner of the "National Outstanding Youth Fund", academic leader of the "Innovative Research Group" of the National Natural Science Foundation of China, chief scientist of the National Key R&D Program, and editorial board member of the international high-end biology journal "eLife". Mainly engaged in the research of non-coding RNA and epigenetic mechanisms, he has made a series of important research results, discovered and named a variety of new types of small RNA, and published a large number of papers in important international academic journals such as Nature, Cell, and Molecular Cell. He has won the Tan jiazhen Life Science Innovation Award, the China Youth Science and Technology Award and the Second Prize of the National Natural Science Award.
Jia Qu, male, ophthalmologist, director of the National Clinical Research Center for Ophthalmology, Director of the State Key Laboratory of Ophthalmology and Vision Science, Director of the National Optometry Engineering Technology Research Center, Director of the Key Laboratory of Clinical Research and Evaluation of Medical Devices and Drugs for Ophthalmic Diseases of the State Food and Drug Administration. He was the president and member of Wenzhou Medical University in Zhejiang Province. In November 2018, he won the "Medical Pharmacy Award" and the Clinical Medicine Award of the Foundation Science and Technology Award.
His main research interests are optometry and optometry, basic and clinical prevention and control of myopia, functional eye disease research, ophthalmic device research and development, and real-world research on ophthalmic medicines and devices. Professor Qu Jia is the main pioneer of optometry higher education in China, integrating ophthalmology and optometry, and created the first eye optics major in Wenzhou Medical College in 1988, and the first optometry hospital in China in 1998. Professor Qu Jia has been engaged in clinical and teaching work for more than 30 years, and is the main pioneer of optical higher education in China.
<h1 class="pgc-h-arrow-right" data-track="119" > Lijia Qu, Professor Jiang of the School of Life Sciences, Peking University, Deputy Director of the State Key Laboratory of Protein Engineering and Plant Genetic Engineering of Peking University, and Deputy Director of the Peking University-Yale Joint Research Center for Plant Molecular Genetics and Agricultural Biotechnology. </h1>
Song Baoliang, male, was born on January 19, 1975 in Linzhou City (LinXian County), Henan Province. He received his B.S. from Nanjing University in 1997 and his Ph.D. from the Institute of Biochemistry and Cell Biology from the Shanghai Institute for Biological Sciences, Chinese Academy of Sciences in 2002, and then conducted postdoctoral research at the Southwestern Medical Center. In 2005, he was funded by the "Hundred Talents Program" of the Chinese Academy of Sciences to introduce foreign outstanding talents, and served as the research team leader and researcher of the Institute of Biochemistry and Cell of the Shanghai Academy of Biological Sciences. He served as the chief scientist of the major protein research program of the Ministry of Science and Technology, supported by the National Outstanding Youth Fund, and the final evaluation of the "100 Talents Program" was excellent. On February 28, 2014, after the study and decision of the Party Committee of Wuhan University, Song Baoliang was appointed as the dean of the School of Life Sciences of Wuhan University for a term of office from March 1, 2014.
Teng Gaojun, MD, Chief Physician, Chief Professor and Doctoral Supervisor of Southeast University, 82nd Alumnus of the Department of Radiology of Shaoxing College of Arts and Sciences, is currently the President of the Affiliated University Hospital of Southeast University, the Director of the Interventional Therapy Center, the Director of the Jiangsu Provincial Key Laboratory of Molecular Imaging and Functional Imaging, the President of the Interventional Physician Branch of the Chinese Medical Doctor Association, the Vice President of the Radiologists Branch of the Chinese Medical Doctor Association, and the Former President of the Asia-Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) (2016-2018), Associate Editor of Cardiovascular and Interventional Radiology (CVIR) and Associate Editor of J Vascular & Interventional Radiolgy (JVIR).
He has presided over more than 10 national projects of the Ministry of Science and Technology 973 Project (Chief Scientist), National Transformative Technology, 863 Project, National Natural Science Foundation of China Key Project, and Major International Cooperation Project. He has won 3 second prizes of the National Science and Technology Progress Award, and published more than 200 PAPERS including SCI, including Lancet Oncology, Lancet Gastroent Hep, Radiology, JACC, J Hepatology, PNAS, etc. Won the American Interventional Radiology Society fellow (FSIR), the European Cardiovascular Interventional Society fellow (FCIRSE); He has received distinguished Fellow (2015) from the European Society of Interventional Radiology (CIRSE), Gold Medal (2017), the highest honor of the American Society for Interventional Radiology (SIR), and gold medal (APSCVIR) (Gold Medal, 2019). He was awarded the Outstanding Contribution of the Ministry of Health as a Young and Middle-Aged Expert (2006), a Special Allowance of the State Council (2002), and a first-level training object of the 333 Project in Jiangsu Province.
Wang Daowen, male, is a professor of cardiovascular medicine at Wuhan Tongji Hospital, chief physician, director of the Department of Internal Medicine, director of the Department of Cardiovascular Medicine, director of the Institute of Hypertension, director of the Center for Translational Medicine and Genetic Diagnosis, and doctoral supervisor.
Professor Wang Daowen has been practicing medicine for more than 30 years, has been committed to the clinical diagnosis and treatment of cardiovascular medicine and scientific research, led his academic team to engage in clinical and basic research on cardiovascular diseases for a long time, carried out research on risk factors for cardiovascular and cerebrovascular diseases and research on endogenous protection mechanisms, promoted the application of evidence-based medicine in the clinic, established a standardized treatment system for diseases, and has unique characteristics in the standardized diagnosis and treatment of hypertension; and took the lead in carrying out genetic diagnosis of diseases and individualized diagnostic medicine based on genetic diagnosis and typing in the country.
He has carried out more than 600 genetic diagnosis projects, solving a large number of difficult problems for clinical practice, and leading the world in genetic diagnosis of arrhythmias, hypertrophic cardiomyopathy, infantile jaundice and large vascular diseases. In clinical practice, he adheres to the principle of clear diagnosis and treatment, actively carries out new technologies and new businesses, and makes the condition of many difficult and critically ill patients correctly diagnosed and treated.
Wang Yizheng, male, graduated from China Medical University in 1982, received a master's degree from the Chinese Academy of Military Medical Sciences in 1985, and a doctorate in biochemistry and experimental medicine from Laval University in Canada in 1991. From 1991 to 1994, he worked as a postdoctoral fellow at Case Western Reserve University in the United States and at nice university in France. From 1995 to 2001, he served as an assistant professor and associate professor at national research council in Canada and Thomas Jefferson University in the United States, mainly studying the signaling pathway of glutamine and the mechanism of neuron survival and death, etc. His main research results were published in internationally renowned academic journals such as Science. After returning to China in August 2001, he served as the leader of the neural signal transduction research group of the Institute of Neuroscience of the Chinese Academy of Sciences, a researcher, a doctoral supervisor, a member of the Education Committee of the Institute, and a member of the Scientific Research Plan Committee of the Institute. He is currently a researcher at the Academy of Military Medical Sciences of the People's Liberation Army of Chinese.
Wang Yongjun, male, born on September 2, 1962, Han ethnicity, member of the Communist Party of China. Chief physician, professor, doctoral supervisor. He is currently the president of Beijing Tiantan Hospital affiliated to Capital Medical University, the director of the Neurology Center, the deputy director of the National Clinical Research Center for Neurological Diseases, the director of the Quality Control Center of neurology of the National Health and Family Planning Commission, and the executive vice president of the Chinese Stroke Society.
Professor Wang Yongjun has long been engaged in research on the causes and pathogenesis of cerebrovascular diseases, and the establishment of key prevention and treatment technologies and systems. He has published more than 300 SCI journal papers in the New England Journal of Medicine, JAMA, Circulation and other magazines, and has been cited more than 1,000 times by him. Among them, the new short-course, early and optimized antiplatelet therapy technology for high-risk non-disabling cerebrovascular disease was rated as "2013 International Major Progress in Medicine" by the New England Journal of Medicine and Lancet Neurology as "one of the eight annual advances in the field of international neurology". Established the first cerebrovascular disease etiology and pathogenesis classification in China, CISS classification, to achieve hierarchical management of cerebrovascular disease, and created China's first national coverage of cerebrovascular disease medical quality research platform, significantly improving the quality of cerebrovascular disease prevention and control.
Wang Yongjun et al. established for the first time a risk assessment system for ischemic cerebrovascular disease that meets the characteristics of Chinese groups. For the first time, the correlation between various risk predictors such as metabolic syndrome and stroke outcomes was clarified in a large sample size of Chinese population, and a variety of risk assessment scales such as CHADS2 were verified, in addition, a new post-stroke pneumonia prediction scale (AIS-APS) for Chinese people was created, laying a solid foundation for the establishment of a risk assessment system suitable for Chinese populations. The findings were published continuously in the industry's top magazine, Stroke. The research team led by Wang Yongjun has become the largest contribution team of the global single center of Stroke Magazine for 6 consecutive years, and has won the title of the first batch of outstanding innovation teams in key areas of the Ministry of Science and Technology (2013).
Wu Hao, male, born in 1964, member of the Communist Party of China, doctor of medicine, professor, chief physician, doctoral supervisor. He is currently the President of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the Director of the Institute of Ear Sciences of Shanghai Jiao Tong University School of Medicine, the Director of the Department of Otorhinolaryngology of Shanghai Jiao Tong University School of Medicine, the Director of the Clinical Moderate Control Center of the Department of Otolaryngology of Shanghai Municipality, and the Director of the Shanghai Children's Hearing Impairment Diagnosis and Treatment Center.
He is now the discipline leader of the National Clinical Key Specialty, the "Top Priority" Clinical Key Discipline in Shanghai, and the Key Discipline of Shanghai Jiao Tong University School of Medicine, and undertakes a number of national, provincial and ministerial scientific research projects. His monographs include Clinical Auditory Physiology, Temporal and Lateral Skull Base Anatomy Training Manual, Surgical Treatment of Ear and Ear Nerve Diseases, Otolaryngology Head and Neck Oncology, Pediatric Oncology, Clinical Otolaryngology Head and Neck Oncology, Neurinology neurological and neurological excellence, Ear Surgery, Le Neurinome de l'Acoustique La Neurofibromatose de Type II, Department of Otorhinolaryngology Head and Neck Surgery (Textbook of the "Eleventh Five-Year Plan" of the Ministry of Health), "Department of Otorhinolaryngology Head and Neck Surgery" (Textbook of the "Twelfth Five-Year Plan" of the Ministry of Health).
On January 6, 2021, the Cell Report published the results of the team of wu hao, professor of the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, researcher Hua Yunfeng, and professor Moser of the University of Göttingen in Germany. This study establishes a new method for imaging cochlear neural circuits, and proposes that the cochlear auditory nerve can integrate a variety of external sound signals and is closely and diversely regulated by the center, which opens up a new research direction for the field of hearing.
Xue Yongbiao, male, researcher, doctoral supervisor, winner of the Family Outstanding Youth Science Fund, chief scientist of the leading project of molecular module design and breeding innovation system of the Chinese Academy of Sciences.
The research group focuses on the reproductive disorders and molecular mechanisms of growth and development of flowering plants. For the first time, the SLF (S-locus F-box) gene, which controls the incompatibility of snapdrop pollen incompatibility, was cloned, and the SCF-like E3 ubiquitin ligase complex consisting of SLF, SSK1 (SLF-interacting SKP1-like1) was found to play a decisive role in the inbred incompatibility reaction, and the molecular genetic mechanism of plant adaptive growth and development was studied. The research focuses on the following three directions: the molecular mechanism of inbred disapproval, the molecular mechanism and evolution of speciation, and the molecular genetic mechanism of rice complex traits.
Yang Ruifu, male, born in 1963 in Langfang, Hebei Province, graduated from the Medical Department of Hebei Medical University in 1985, obtained a master's degree in medicine from the Academy of Military Medical Sciences in 1988, and a doctorate degree in science from the Academy of Military Medical Sciences in 2002. He is currently the director of the State Key Laboratory of Pathogenic Microorganisms at the Institute of Microbiology and Epidemiology of the Academy of Military Medical Sciences, and the director of the Laboratory of Analytical Microbiology of the National Biomedical Analysis Center. In 2004, he was funded by the National Natural Science Foundation of China, and in 2005, he was awarded the National Science Foundation for Outstanding Youth. In 2009, he became the chief scientist of the National 973 Project.
He has long been engaged in the microevolution and pathogenic mechanism of pathogenic bacteria, pathogenic microbial detection technology (biosensors and biochips) and microbial forensic science. He has undertaken dozens of projects such as the National 973 Program, the 863 Program, the National Natural Science Foundation of China, the major special projects for the prevention and treatment of major infectious diseases, and the military's scientific and technological research plan, won 1 first prize for military scientific and technological progress, 1 Chinese invention patent, 4 utility model patents, published more than 100 SCI academic papers, with a cumulative impact factor of more than 300, a cumulative H factor of 22, and a single maximum impact factor of 53.5. In 2002, he was awarded the title of "Silver Star of Science and Technology" by the General Logistics Department, and in 2004, he enjoyed the first-class allowance for military talents, and edited 6 monographs, including "Dictionary of English Interpretation of Bacterial Names", "Dictionary of Double Interpretation and Classification of Bacterial Names", "Biological Threats and Verification", "Acute Respiratory Distress Syndrome", and "Microbiological Forensic Science".
Yang Shiming, male, director of the Department of Otolaryngology, Head and Neck Surgery, Chief Physician, Professor, Doctoral Supervisor, PLA General Hospital.
He has successfully completed more than 1,000 difficult surgeries in ear microsurgery and ear neurosurgery, including hearing reconstruction, stirrup surgery, facial neurosurgery, temporal bone and lateral skull base tumor resection. More than 5,000 cases of ear endoscopy have been carried out, which has improved the diagnostic accuracy of preoperative middle ear lesions and significantly improved the efficacy of ear microsurgery; the ear endoscopic technology has been further applied to pontocebellar angle surgery, successfully removed tumors and successfully preserved residual hearing on the basis of good facial nerve function, reaching the international advanced level and winning the military medical achievement award.
Responsible for drafting and developing the "Guidelines for the Diagnosis and Treatment of Sudden Deafness". On this basis, it has taken the lead in proposing and initiating the "China Multi-center Clinical Research on Sudden Deafness", and is leading the 22 medical centers with the strongest otological research strength in the country to carry out clinical research on sudden deafness, and promoting the standardization of the diagnosis and treatment of sudden deafness nationwide.
Yang Weicai, researcher, doctoral supervisor, director of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, was supported by the "Hundred Talents Program" of the Chinese Academy of Sciences in 2004. Recipient of the National Science Foundation for Outstanding Young Scholars in 2004.
His research interests are the molecular genetics of plant reproductive development, especially the molecular genetic mechanisms of cell polarity, cell fate, cell differentiation and hermaphroditonic gamete cell interaction during female gametophyte and embryonic development. Its goal is to use model plants such as Arabidopsis thaliana and rice to explore the basic problems of developmental biology, and to study crop gene function as a model. As the first author or corresponding author, he has published more than 80 papers in international first-class journals such as Nature, PNAS, plant cell and so on.
Yang Zhenglin, male, Han ethnicity, member of the Communist Party of China, born in June 1966, on-the-job doctoral candidate, chief technician, researcher, director of the Sichuan Provincial Key Laboratory of Human Disease Genetic Research, chairman of the Laboratory Professional Committee of the Sichuan Medical Association, doctor, professor/researcher, doctoral supervisor. Adjunct Professor of Chengdu Institute of Biology, Chinese Academy of Sciences, Sichuan University, Southwest Jiaotong University, Chongqing Medical University. He is currently the deputy secretary of the party committee and president of the Sichuan Academy of Medical Sciences (Sichuan Provincial People's Hospital).
During his tenure as the deputy director of the Laboratory Department, he actively planned for the development of the department, standardized the laboratory operation and clinical specimen collection behavior, and provided a favorable guarantee for the normal operation of the quality system of the laboratory department and the smooth passage of the ISO15189 review. Actively participate in the inter-room quality assessment organized by the Ministry of Health and achieve excellent results, and constantly carry out new technologies and new experiments. From the initial 3-5 test items to more than 30.
Guide hospitals at all levels in the province to establish standardized and qualified PCR laboratories, establish a provincial PCR interventricular quality evaluation system, collect and complete THE FISH testing of 200 cases of cervix, chronic lymphocytic leukemia, and multiple myeloma, and establish a clinical application platform. At the same time, it cooperated with the Department of Obstetrics and Gynecology to complete the preparation of the prenatal diagnosis center, laying the foundation for further establishing the largest and highest-level disease gene research and clinical testing center in the province and even western China.
Zhang Keqin, male, professor, doctoral supervisor, vice president of Yunnan University. Focusing on the biological control of crop pathogenic nematodes, it has made important contributions to solving the problem of nematode control by excavating new resources and new compounds of nematode microorganisms, determining the virogenic force factors, revealing the molecular mechanism of interaction between microorganisms and nematodes, developing nematode biopesticides with independent intellectual property rights and realizing the large-scale production and application of products.
He has presided over many major projects such as the National Science and Technology Research Project, the National High-tech Industrialization Project, the National Major Basic Preliminary Research Project (973 Pre-research), the National Natural Science Foundation of China, the Achievement Transformation Project of the Ministry of Finance, and the Yunnan Provincial Science and Technology Research Project. He has published more than 150 papers in Journals such as Mycological Research, Mycologia, Fungal Diversity, Nova Hedwigia, Cryptogamie Mycologie, Mycosystema, Journal of Mycosystema, Journal of Plant Pathology, etc., including 65 SCI papers. Applied for 10 invention patents; He has published four monographs, including "Research on Nematode Fungi", "Taxonomy of Nematode Bacteria", and "Biology of Nematode Bacteria". He has been rated as a national youth science and technology pacesetter, a national outstanding teacher, in 2002 won the fifth "China Outstanding Youth Science and Technology Innovation Award", in 1994 won the first prize of Guizhou Province Science and Technology Progress Award (ranked first), in 2001 won the first prize of Yunnan Province Science and Technology Progress Award (ranked first), presided over the completion of the "root knot nematode biocontrol fungal resources research and application" project in 2004 was awarded the second prize of the National Science and Technology Progress Award. In November 2006, he won the "Science and Technology Innovation Award" of the Ho Leung Ho Lee Foundation.
Zhang Xianen, male, research fellow, Institute of Biophysics, Chinese Academy of Sciences. Engaged in interdisciplinary research in life science and analytical science, involving: analysis of pathogenic microbiology, biological sensing, cell molecular imaging, nanobiology, etc. He has served as the director of the Department of Basic Research of the Ministry of Science and Technology, engaged in the macro-management of national basic research, and published or edited "30 Years of Prosperity and Development of Basic Research in China", "New Joseph Needham's Proposition", "Overview of International Science and Technology Awards", "Scientific and Technological Innovation and the Road to a Strong Country" and other works.
He has published more than 170 research papers and 3 monographs on biosensors and biochips. He has won the first Young Scientist Award of the Chinese Academy of Sciences (1989), the Chinese Academy of Sciences outstanding contributions to young and middle-aged experts (1994) and other honors.
Zhang Xu, male, born in 1962, from Jingzhou, Hubei Province. He is currently the director of the Department of Urology, Professor, Chief Physician and Doctoral Supervisor of the General Hospital of the People's Liberation Army of Chinese. He is a member of the expert group of the Central Health Commission, a leading scientific and technological talent of the whole army, and a recipient of the National Science Fund for Outstanding Youth.
As the first author or corresponding author, he has published more than 100 SCI papers in international authoritative journals such as European Urology, Nature Communications, Clinical Cancer Research, Cancer Research, The Journal of Urology, BJU International and so on.
He has long been committed to the application research and promotion of urological surgical techniques, especially minimally invasive laparoscopic techniques in urology. Through technical research, a set of urological laparoscopic surgery technology system featuring retroperitoneal approach has been created, and more than 8,000 cases of urological laparoscopic surgery have been completed; after nearly 20 years of promotion, posterior laparoscopic technology has become a general technical system of urology in China, and has been promoted and applied in Europe, America and Southeast Asia, rapidly improving the level of laparoscopic and robotic surgery in Urology in China. For his outstanding contributions in the field of laparoscopic technology in urology, he won the second prize of the National Science and Technology Progress Award in 2013 and 2006 and the National Outstanding Youth Science Fund in 2007. It took the lead in carrying out urological robotic surgery in China systematically, and the number of personal robot surgeries reached 3,000 cases by 2017. The organic combination of positral abdominal technology and robot technology has formed a robot technology with Chinese characteristics and widely promoted and applied throughout the country.
Zhang Zhibin, male, born in June 1964, Ph.D., researcher, doctoral supervisor; Leader and researcher of the Research Group of Agricultural Animal Ecology, Institute of Zoology, Chinese Academy of Sciences; Foreign member of the Norwegian Academy of Sciences and foreign member of the European Academy of Sciences. From the perspectives of behavioral ecology, molecular ecology, physiological ecology, population ecology and global ecology, the law and regulation mechanism of outbreaks and disasters of rodents and other harmful organisms, the relationship between rodents and plants and diseases, and pollution-free and sustainable control technologies and strategies are studied, so as to provide technical support and scientific basis for early warning and comprehensive management of biological disasters and the restoration and reconstruction of degraded ecosystems.
He has published more than 200 academic papers, including more than 70 SCI papers. It is found that climate warming in the past millennium has significantly reduced the three major agricultural natural disasters in China (drought, flood and locust plague), enso is found to be closely related to the dynamics of rodent populations in China, Europe and other countries, and it is found that the reciprocity or cooperation of density dependence is conducive to the coexistence of competitors and improve competitiveness.
Zhu Bing, male, researcher, winner of the National Outstanding Youth Science Fund, is currently the deputy director of the Institute of Biophysics of the Chinese Academy of Sciences, was selected as an international young scientist at the Howard-Houston School of Medicine in 2012, and won the Tan Jiazhen Life Science Award in 2014. Researcher Zhu Bing has long been engaged in the research of the mechanism of establishment and maintenance of epigenetic information, and has published more than 50 papers in nature, Science, Molecular cell and other journals, and a number of research results have entered epigenetics textbooks.
Zhu Lan, female, born in 1964, doctor of medicine, professor of obstetrics and gynecology of The Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, and doctoral supervisor. He serves as the vice president of the Chinese Health Science and Technology Promotion Association and the secretary of the Obstetrics and Gynecology Branch of the Chinese Medical Association. Deputy Leader and Secretary of pelvic floor group of obstetrics and gynecology branch of Chinese Medical Association. Associate Editor of The Journal of Practical Obstetrics and Gynecology and the Chinese Journal of Practical Gynecology and Obstetrics, the core journals of obstetrics and gynecology. He is a member of the editorial board of more than ten magazines such as the Chinese Journal of Obstetrics and Gynecology.
A national-level candidate for the Millions of Talents Project in the new century. Winner of the 9th China Youth Science and Technology Award and the 2nd Wuzhou Women's Science and Technology Award of the Chinese Association of Women Physicians. The National Natural Science Foundation of China is a specially appointed review expert, enjoys the special government allowance of the State Council, and is the first member of the National Health Science Popularization Expert Database.
Engaged in obstetrics and gynecology for more than 20 years, in 1989, he worked in the Department of Obstetrics and Gynecology of Union Hospital, where he studied under the well-known experts of the older generation of Concord. Comprehensive knowledge of obstetrics and gynecology, solid theoretical foundation and rich practical experience, proficient in the diagnosis and treatment of common and difficult diseases in obstetrics and gynecology. At the University of New South Wales in Australia, majoring in gynecological urology and pelvic floor reconstruction and gynecological endoscopy, he mastered the new concepts and new technologies in the field, gradually worked after returning to China, and promoted the development of the field throughout the country. In practice, we have been brave in innovation and created a new surgical method that conforms to the anatomical characteristics of Asian races and is cost-effective for pelvic floor reconstruction: sciatica acanthocepioscular fascial fixation and improved full pelvic floor reconstruction, the latter is known as the "concord technique", which is promoted and applied in dozens of hospitals across the country, and the efficacy and long-term prognosis are similar to foreign full pelvic floor surgery, directly saving tens of millions of yuan in medical expenses.
Source | Cas
Edit | Small ears